Drug companies are increasingly offering price discounts and subsidies to patients in exchange for their medical data. The details of that exchange can be easy to miss: They're in the fine print.
Read Full Article »
Drug companies are increasingly offering price discounts and subsidies to patients in exchange for their medical data. The details of that exchange can be easy to miss: They're in the fine print.